Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX ®) in hemodialysis patients

Vaccine

Volumn 23, Issue 5, 2004, Pages 656-663

  Fattom, Ali ^a   Fuller, Steve ^a   Propst, Myra ^a   Winston, Scott ^a   Muenz, Larry ^b   He, David ^b   Naso, Robert ^a   Horwith, Gary ^a  

^a Nabi Biopharmaceuticals   (United States)

^b Larry Muenz and Associates   (United States)

Author keywords

Conjugate vaccines; Hemodialysis; Staphylococcus aureus

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PLACEBO; POLYSACCHARIDE VACCINE; STAPHVAX; STAPHYLOCOCCUS VACCINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; ERYTHEMA; FEMALE; HEAT; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION PAIN; INJECTION SITE; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INDURATION; STAPHYLOCOCCUS INFECTION; VACCINATION REACTION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; KIDNEY FAILURE; MALE; MIDDLE AGED; OPSONIN PROTEINS; PLACEBOS; POLYSACCHARIDES, BACTERIAL; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 8144225903     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.043     Document Type: Article

References (34)

1. D. Pittet, and R.P. Wenzel Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths Arch Intern Med 155 11 1995 1177 1184
2. F.R. Cockerill III, J.G. Hughes, and E.A. Vetter Analysis of 281, 797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood Clin Infect Dis 24 3 1997 403 418
3. M.A. Pfaller, R.N. Jones, G.V. Doern, and K. Kugler Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) Antimicrob Agents Chemother 42 7 1998 1762 1770
4. M.J. Richards, J.R. Edwards, D.H. Culver, and R.P. Gaynes Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27 5 1999 887 892
5. A. Goetz, K. Posey, and J. Fleming Methicillin-resistant Staphylococcus aureus in the community: a hospital-based study Infect Control Hosp Epidemiol 20 10 1999 689 691
6. F.D. Lowy Staphylococcus aureus infections N Engl J Med 339 8 1998 520 532
7. R.J. Rubin, C.A. Harrington, A. Poon, K. Dietrich, J.A. Greene, and A. Moiduddin The economic impact of Staphylococcus aureus infection in New York City hospitals Emerg Infect Dis 5 1 1999 9 17
8. J.B. Robbins Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future Immunochemistry 15 1978 839 854
9. J.B. Robbins, R. Schneerson, and S.C. Szu Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates Curr Top Microbiol Immunol 146 1989 169 180
10. Seminars in infectious disease W.W. Karakawa W.F. Vann L. Weinstein B.N. Fields Capsular polysaccharides of Staphylococcus aureus 1982 Thieme-Stratton New York 285 293
11. T. Na'was, A. Hawwari, and E. Hendrix Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients J Clin Microbiol 36 2 1998 414 420
12. T. Essawi, T. Na'was, A. Hawwari, S. Wadi, A. Doudin, and A.I. Fattom Molecular, antibiogram and serological typing of Staphylococcus aureus isolates recovered from Al-Makased Hospital in East Jerusalem Trop Med Int Health 3 7 1998 576 583
13. R.D. Arbeit, W.W. Karakawa, W.F. Vann, and J.B. Robbins Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus Diagn Microbiol Infect Dis 2 2 1984 85 91
14. W.W. Karakawa, A. Sutton, R. Schneerson, A. Karpas, and W.F. Vann Capsular atibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes Infect Immun 56 1988 1090 1095
15. A.I. Fattom, J. Sarwar, A. Ortiz, and R.A. Naso Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge Infect Immun 64 5 1996 1659 1665
16. J.C. Lee, J.S. Park, S.E. Shepherd, V. Carey, and A. Fattom Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats Infect Immun 65 10 1997 4146 4151
17. P.G. Welch, A. Fattom, and J. Moore Jr. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide - Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis J Am Soc Nephrol 7 2 1996 247 253
18. L.A. Pirofski, and A. Casadevall Use of licensed vaccines for active immunization of immunocompromised host Clin Microbiol Rev 11 1998 1 26
19. C. Nolan, H. Beaty, and J. Bagdade Impaired granulocyte bactericidal function in patients with poorly controlled diabetes Diabetes 127 1978 889 894
20. Haag-Weber M, Hable M, Schollmeyer P, Hort W, urth SL. Metabolic response of neutrophils to uremia and dialysis. Kidney Int 1989;36(suppl 27):S293-8.
21. A. Fattom, R. Schneerson, S.C. Szu, W.F. Vann, J. Shiloach, and J.B. Robbins Synthesis and immunologic properties in mice of vaccines composed of S. aureus type 5 and type 8 capsular polysaccharide conjugated to Pseudomonas aeruginosa exotoxin A Infect Immun 58 1990 2367 2374
22. A. Fattom, R. Schneerson, and D.C. Watson Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A Infect Immun 61 3 1993 1023 1032
23. H. Shinefield, S. Black, and A. Fattom Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis N Engl J Med 346 7 2002 491 496
24. G.R. Siber Methods for estimating serological correlates of protection Dev Biol Stand 89 1997 283 296
25. Rogers DE, Melly MA. Speculation on the immunology of staphylococcal infection. Ann N Y Acad Sci 1965;128:M274-84.
26. R.M. Krause Immunity to S. aureus, a persistant enigma Emory Univ J Med 3 1989 77 85
27. R. Schneerson, J.B. Robbins, and J.C. Parke Jr. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates Infect Immun 52 2 1986 519 528
28. A. Fattom, C. Lue, and S.C. Szu Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid Infect Immun 58 7 1990 2309 2312
29. J.B. Robbins, and R. Schneerson Polysaccharide-protein conjugates: a new generation of vaccines J Infect Dis 161 5 1990 821 832
30. P. Anderson Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197 Infect Immun 39 1 1983 233 238
31. T. Barington, A. Gyhrs, K. Kristensen, and C. Heilmann Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine Infect Immun 62 1 1994 9 14
32. A. Fattom, Y.H. Cho, C. Chu, S. Fuller, L. Fries, and R. Naso Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines Vaccine 17 2 1999 126 133
33. D.M. Granoff, S.J. Holmes, R.B. Belshe, M.T. Osterholm, J.E. McHugh, and E.L. Anderson Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants JAMA 272 14 1994 1116 1121
34. T. Barington, K. Kristensen, J. Henrichsen, and C. Heilmann Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine Infect Immun 59 3 1991 1057 1064